SUBSCRIBE
SUBSCRIBE

GLP-1

Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Novo Nordisk A/S’s Liraglutide Safe, Effective For Obesity: FDA Panel
September 12, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
FDA Initial Briefs Find Novo Nordisk A/S’s Liraglutide Effective
September 10, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Spinach Decreases Cravings And Helps With Weight Loss, Lund University Study
September 3, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Job Trends
Novo Nordisk A/S Drops Inflammatory Disorder Business; 400 Staffers Impacted
September 2, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Lone Star Bio
New Estrogen-Based Compound May Curb Binge Eating, Baylor College of Medicine Study
August 28, 2014
 · 
4 min read
Job Trends
Novo Nordisk A/S Buys Plant In New Hampshire; Ex-Workers Offered Jobs
August 27, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ETH Zurich Release: Sensitive Acid Sensor Controls Insulin Production
August 11, 2014
 · 
4 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Is This One Drug Enough To Revive Hope In Eli Lilly and Company’s Pipeline?
March 5, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
BioForest
Pacific Biomarkers, Inc. Announces Ultra-Sensitive Assay Services To Detect Drug-Entities And Biomarkers In Human And Animal Sera
February 27, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
Clock Is Ticking For AstraZeneca PLC
February 26, 2014
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China
February 11, 2026
 · 
4 min read
Press Releases
Kailera Therapeutics and Hengrui Pharma Report Positive Topline Data from Phase 2 Obesity Trial of Oral Ribupatide
February 10, 2026
 · 
8 min read
Press Releases
Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
February 4, 2026
 · 
9 min read
Press Releases
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
February 3, 2026
 · 
6 min read
Press Releases
Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility
February 1, 2026
 · 
8 min read
Press Releases
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
January 30, 2026
 · 
5 min read
Press Releases
BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple
January 30, 2026
 · 
2 min read
Press Releases
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation
January 29, 2026
 · 
8 min read
Press Releases
Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users
January 28, 2026
 · 
3 min read
Press Releases
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
January 28, 2026
 · 
3 min read
Press Releases
Baseline Therapeutics Launches to Advance GLP-1RA Phase 3 Program in Alcohol Use Disorder
January 28, 2026
 · 
3 min read
Press Releases
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity
January 27, 2026
 · 
4 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity
January 27, 2026
 · 
6 min read
Press Releases
Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
January 26, 2026
 · 
4 min read
Press Releases
CORXEL Announces $287 million Series D1 Financing to Further Advance Its Cardiometabolic Pipeline including Oral Small Molecule GLP-1 Receptor Agonist
January 23, 2026
 · 
3 min read
Press Releases
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
January 20, 2026
 · 
4 min read
Press Releases
RO ANNOUNCES RESEARCH COLLABORATION TO BETTER UNDERSTAND AND IMPROVE THE REAL-WORLD PATIENT EXPERIENCE WITH GLP-1S
January 13, 2026
 · 
2 min read
Press Releases
Kailera Therapeutics Announces First Participants Randomized in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide (KAI-9531)
January 13, 2026
 · 
6 min read
Press Releases
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
January 12, 2026
 · 
8 min read
Press Releases
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
January 9, 2026
 · 
6 min read
Load More